EPA Urged To Redo Methylene Chloride Method To Bolster Cost-Benefit Study

September 18, 2020
A university researcher is suggesting the agency redo a core component of its risk analysis for methylene chloride, which causes non-cancer effects to the nervous system, in a way that it usually assesses cancer risks -- an approach that could bolster any cost-benefit analysis the agency conducts to justify its upcoming risk management rules under TSCA. Nicholas Chartres, associate director of science and policy at the University of California San Francisco’s Program on Reproductive Health and the Environment, urged officials...

Not a subscriber? Sign up for 30 days free access to exclusive environmental policy reporting.